Dynavax Technologies Corporation
|
 | ||||||||
|
 |
  |
 |
|
|
||
 |
 |
 
 |
return to message board, top of board |
Re: Strategic RestructuringI want to add that these SD-101 trials are the "only" trials Dr. Antoni Ribas is presenting at ASCO19. He is a big name in immunotherapy. He just got elected president-elect at AACR. Like you said, I wish he does not go to ASCO19 just for the embarrassment.
|
||||||||||||||||||
|
|
return to message board, top of board |
